NCATS Funding Opportunities for Clinical Trial Readiness
The National Center for Advancing Translational Sciences announced two new funding opportunities focused on clinical trial readiness in rare diseases:
Call for Proposals: TSC2+/- A/J Mice – Due October 22
The TSC Preclinical Consortium is currently running three animal models, one of which is the Tsc2+/- A/J strain (Woodrum et al 2010, Guo and Kwiatkowski 2013). Large cohorts of age-matched mice are bred for testing candidate drugs using standardized protocols at a contract research organization. However, as a by-product of growing the colony, we have smaller numbers of non-age-matched mice, which could provide valuable data for other research questions.